Skip to main content
Fig. 5 | BMC Medical Genomics

Fig. 5

From: Stemness related lncRNAs signature for the prognosis and tumor immune microenvironment of ccRCC patients

Fig. 5

The impact of risk score on ccRCC patients’ prognosis in clinical subgroups. (A-H, K-N) In all different clinical subgroups except N stage, in comparison to patients in low risk groups, those in high risk groups had a decreased survival probability. (I and J) Among different N stage groups, patients’ survival probability was lower in high than low risk, the difference in N 0 stage was significant, but the difference in N 1 stage was not significant. (O) In all patients, the survival productivity was lower in high than the low risk groups. * p < 0.05, * * p < 0.01, * * * p < 0.001

Back to article page